About Daiichi Sankyo India Pharma Private Limited
Data last updated:
Daiichi Sankyo India Pharma Private Limited was a private limited company based in Gurgaon, Haryana, India, operated as a subsidiary of Daiichi Sankyo Company Limited. The company has been dissolved (liquidated) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the book and digital publishing segment of the media and publishing sector. It was incorporated on 13 March 2007.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24233HR2007PTC044362. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹178 Cr and a paid-up capital of ₹177 Cr. It was led by directors including Masahiko Otsuki and Takashi Mochizuki.
Its last annual general meeting (AGM) was held on 28 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Gurgaon, Haryana.
As per the financials filed for FY 2015, the company reported a revenue of ₹184.98 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹24.91 Cr (net margin 13.5%) and EBITDA of ₹42.52 Cr (EBITDA margin 23%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The company had about 9 employees on its provident fund (EPFO) records before it was dissolved.
Court records list 1 case involving the company, including 1 filed by the company.
The last known website on record is dsin.co.in.
Company details
CIN history
Daiichi Sankyo India Pharma has one previous CIN (Corporate Identification Number): U24233MH2007PTC168691. The current CIN is U24233HR2007PTC044362, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233HR2007PTC044362 | Current |
| U24233MH2007PTC168691 | Previous |
Contact details
Daiichi Sankyo India Pharma Private Limited's registered office is in Gurgaon, Haryana. Its website is dsin.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit 62 Level 18 One Horizon Center Golf Course Road DLF Phase 5 Sector – 4, 3, Gurgaon, Haryana, India – 122002
- IndustryMedia and Publishing, Book & Digital Publishing
To see the full contact details of Daiichi Sankyo India Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Daiichi Sankyo India Pharma Private Limited
FY 2016 filings availableDaiichi Sankyo India Pharma Private Limited reported revenue of ₹184.98 Cr (up 3% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years, including 3% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | ₹184.98 Cr |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹42.52 Cr |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹24.91 Cr |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | 23% |
| Net Profit Margin | 13.5% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Daiichi Sankyo India Pharma Private Limited, buy the company report.
Board of directors of Daiichi Sankyo India Pharma Private Limited
Daiichi Sankyo India Pharma has 3 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Masahiko Otsuki | Director | 12 Aug 2010 | 16 Years 2 Months | As last reported |
| Takashi Mochizuki | Director | 01 Jul 2017 | 9 Years 4 Months | As last reported |
| Velloor Venkatakrishnan Ranganathan | Director | 01 Jul 2017 | 9 Years 4 Months | As last reported |
Auditor
Daiichi Sankyo India Pharma Private Limited is audited by B. S. R. Associates LLP for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. S. R. Associates LLP | FY 2015 |
Shareholding
The shareholding of Daiichi Sankyo India Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Daiichi Sankyo India Pharma Private Limited, buy the company report.
Legal cases
Daiichi Sankyo India Pharma Private Limited has 1 court case on record: 1 filed by Daiichi Sankyo India Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Chandigarh | Insolvency matter | Filed by the company | Disposed |
To see the full case history of Daiichi Sankyo India Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daiichi Sankyo India Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daiichi Sankyo India Pharma has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Daiichi Sankyo India Pharma Private Limited, buy the company report.
Recent activity
Daiichi Sankyo India Pharma Private Limited has 24 board changes on record since 2007: 3 appointments and 21 cessations. The latest: Takashi Mochizuki ceased to be Additional Director on 28 Aug 2017.
15 earlier events are in the company report.
Frequently asked questions
Daiichi Sankyo India Pharma has been "Dissolved (Liquidated)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Daiichi Sankyo India Pharma was a private limited company based in Gurgaon, Haryana, India. The company worked in book and digital publishing, within the media and publishing industry. It was incorporated on 13 March 2007 and is registered under CIN U24233HR2007PTC044362. The company is recorded as dissolved (liquidated) in MCA records and no longer exists as a legal entity.
Daiichi Sankyo India Pharma was incorporated on 13 March 2007. It is registered with the Registrar of Companies, Delhi.
Daiichi Sankyo India Pharma had 3 directors:
- Masahiko Otsuki - Director
- Takashi Mochizuki - Director
- Velloor Venkatakrishnan Ranganathan - Director
The CIN (Corporate Identification Number) of Daiichi Sankyo India Pharma is U24233HR2007PTC044362. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Daiichi Sankyo India Pharma is at Unit 62 Level 18 One Horizon Center Golf Course Road DLF Phase 5 Sector – 4, 3, Gurgaon, Haryana, India – 122002.
Daiichi Sankyo India Pharma can be reached through the website dsin.co.in. Its registered office is in Gurgaon, Haryana, India.
The latest financial statements of Daiichi Sankyo India Pharma on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 28 September 2016. Year-wise statements from 2015 are in the company report.
No. Daiichi Sankyo India Pharma has 3 GST registrations on record and all of them are cancelled or inactive.
Daiichi Sankyo India Pharma operated in the media and publishing industry, in the book and digital publishing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
